-
2026 Northern Breast Cancer Forum丨Prof. Xueli Mo: From Single-Target Therapy to the ADC Era — Tracing the Evolution of HER2-Positive Advanced Breast Cancer
From trastuzumab opening the door to HER2-targeted therapy, to dual-targeted regimens becoming the cornerstone of first-line treatment, and now to ADCs reshaping survival outcomes, the treatment history of HER2-positive advanced breast cancer reflects the continuous evolution of precision oncology. The 2026 Northern Breast Cancer Forum was successfully held in Qingdao from July 25 to 26.…
-
2026 Northern Breast Cancer Forum丨Prof. Yunjiang Liu: From Endocrine Therapy to Precision Targeted Therapy — Milestones in HR-Positive Breast Cancer
Hormone receptor (HR)-positive breast cancer accounts for approximately 70% of all breast cancer cases. From the early exploration of ovarian ablation more than a century ago, to tamoxifen ushering in the era of endocrine therapy, and then to CDK4/6 inhibitor-based combinations reshaping the treatment landscape of advanced disease, each major therapeutic breakthrough has profoundly altered…
-
First Global Guideline for the Integrated Evaluation of Evidence on the Efficacy of Traditional Chinese Medicine Published
Recently, the China Association of Chinese Medicine (CACM) Group Standard, Integrated Evaluation of Evidence on the Efficacy of Traditional Chinese Medicine was officially released in Beijing. As the world’s first guiding standard for the integrated evaluation of evidence on the efficacy of traditional Chinese medicine (TCM), the standard was jointly developed under the leadership of…
-
EHA 2026 | Prof. Stephen Ansell & Dr. Zhihui Li: Decoding the Future of Hodgkin Lymphoma
How has PD-1 blockade transformed the treatment of Hodgkin lymphoma? Can biomarkers such as CD30 and 9p24.1 amplification further refine precision therapy? And what lessons can HL teach us about the future of T-cell lymphoma? At EHA 2026, Dr. Zhihui Li of Beijing Gaobo BoRen Hospital joined Prof. Stephen Ansell of Mayo Clinic for an…
-
EHA 2026丨Prof. Stephen Ansell and Dr. Zhihui Li: Exploring the Immunobiology and Precision Treatment of Hodgkin Lymphoma
Crossing borders, exchanging insights, and exploring the frontiers of hematology. During the 2026 Congress of the European Hematology Association (EHA), Oncology Frontier – Hematology Frontier invited Dr. Zhihui Li, Director of Beijing Gaobo BoRen Hospital, and Prof. Stephen Ansell of Mayo Clinic for an in-depth discussion on the tumor immune microenvironment and precision treatment of…
-
Pujiang Prostate Cancer Academic Conference | Prof. Fangning Wan: Innovations in Local Therapy, Advances in Systemic Treatment, and Clinical Applications of Cryotherapy for Prostate Cancer
The 2026 Pujiang Prostate Cancer Academic Conference was held in Shanghai from June 26–27, 2026. As treatment strategies for prostate cancer continue to evolve, local therapy has progressed beyond conventional radical surgery toward robot-assisted precision surgery with greater emphasis on functional preservation. Meanwhile, focal therapies such as cryoablation and irreversible electroporation (IRE) have emerged as…
-
Advances in ADC Therapy for Advanced Urothelial Carcinoma | Prof. Kaiwei Yang Reviews the Evolving First- and Later-Line Treatment Landscape
The treatment landscape for advanced urothelial carcinoma (UC) has entered a new era. Antibody-drug conjugates (ADCs) targeting Nectin-4, HER2, and Trop-2 have rapidly transformed clinical practice, while ADCs combined with immune checkpoint inhibitors have become the new standard for first-line treatment. At the 2026 CSCO Annual Meeting, Prof. Kaiwei Yang from the Department of Urology,…
-
Prof. Benkang Shi: Building Academic Synergy Across the Yellow River Region to Advance High-Quality Development of Urology in Shandong
The 3rd Yellow River Urology Congress and the 31st Academic Conference on Urology of the Shandong Medical Association were recently held, bringing together leading urologists from across China to discuss the latest advances in the field, innovations in clinical practice, talent development, and regional collaboration.
Connecting Medical Expertise through Media